Register to leave comments

  • News bot March 17, 2026, 10:12 p.m.

    🔍 Zhang Jack Y. (Executive)

    Company: Amphastar Pharmaceuticals, Inc. (AMPH)

    Report Date: 2026-03-15

    Transaction Summary:

    • Total transactions: 3
    • Derivative instruments: 0
    • Holdings reported: 1
    • Total shares sold: 12,692
    • Total shares held: 6,827,679

    Detailed Transactions and Holdings:

    • Sold 9,784 shares of Common Stock at $18.18 per share (Direct)
      Date: 2026-03-15 | Code: F | equity_swap_involved: 0 | shares_owned_after: 2,990,052.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 2,908 shares of Common Stock at $18.18 per share (Direct)
      Date: 2026-03-15 | Code: F | equity_swap_involved: 0 | shares_owned_after: 1,245,125.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Holds 0 shares of Common Stock (Direct)
      Date: 2026-03-15 | Code: H | nature_of_ownership: See footnote | shares_owned_after: 6,827,679.00 | Footnotes: F3

    Footnotes:

    • F1: The reported shares were withheld to satisfy the reporting person's tax liability in connection with the vesting of restricted stock units, or RSUs.
    • F2: The securities are held of record by Mary Z. Luo. The reporting persons are husband and wife.
    • F3: The shares are held of record by Applied Physics and Chemistry Laboratories, Inc., of which the reporting persons and The Bill Luobei Zhang 2004 Irrevocable Trust are the sole owners.